Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 361

1.

CT and MR image fusion of tandem and ring applicator using rigid registration in intracavitary brachytherapy planning.

Oinam AS, Tomar P, Patel FD, Singh L, Rai B, Bahl A.

J Appl Clin Med Phys. 2014 Mar 6;15(2):4206. doi: 10.1120/jacmp.v15i2.4206.

PMID:
24710430
2.

Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.

Shi D, He MY, Zhao ZP, Wu N, Zhao HF, Xu ZJ, Cheng GH.

Asian Pac J Cancer Prev. 2015;16(9):3945-9.

3.

Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.

Nesvacil N, Pötter R, Sturdza A, Hegazy N, Federico M, Kirisits C.

Radiother Oncol. 2013 Apr;107(1):75-81. doi: 10.1016/j.radonc.2012.09.005.

4.

Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer.

Haack S, Nielsen SK, Lindegaard JC, Gelineck J, Tanderup K.

Radiother Oncol. 2009 May;91(2):187-93. doi: 10.1016/j.radonc.2008.09.002.

PMID:
18977049
5.

Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.

Price MJ, Jackson EF, Gifford KA, Eifel PJ, Mourtada F.

Med Phys. 2009 Dec;36(12):5515-24.

PMID:
20095264
6.

Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer.

De Leeuw AA, Moerland MA, Nomden C, Tersteeg RH, Roesink JM, Jürgenliemk-Schulz IM.

Radiother Oncol. 2009 Nov;93(2):341-6. doi: 10.1016/j.radonc.2009.05.003.

PMID:
19515443
7.
8.

Evaluation of an active magnetic resonance tracking system for interstitial brachytherapy.

Wang W, Viswanathan AN, Damato AL, Chen Y, Tse Z, Pan L, Tokuda J, Seethamraju RT, Dumoulin CL, Schmidt EJ, Cormack RA.

Med Phys. 2015 Dec;42(12):7114-21. doi: 10.1118/1.4935535.

9.

A system to use electromagnetic tracking for the quality assurance of brachytherapy catheter digitization.

Damato AL, Viswanathan AN, Don SM, Hansen JL, Cormack RA.

Med Phys. 2014 Oct;41(10):101702. doi: 10.1118/1.4894710.

PMID:
25281941
10.

Assessment of uterus position as a surrogate for high-risk clinical target volume with respect to the applicator position for multiple fractions of brachytherapy in cervical cancer.

Cooper R, Brearley E, Hurmuz P, Musunuru HB, Richardson C, Swift S, Orton J, Bownes P.

Arch Gynecol Obstet. 2014 Dec;290(6):1201-5. doi: 10.1007/s00404-014-3350-1.

PMID:
25001571
11.

Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.

Beriwal S, Kim H, Heron DE, Selvaraj R.

Technol Cancer Res Treat. 2006 Oct;5(5):521-7.

PMID:
16981795
12.

Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer.

Tanderup K, Hellebust TP, Lang S, Granfeldt J, Pötter R, Lindegaard JC, Kirisits C.

Radiother Oncol. 2008 Nov;89(2):156-63. doi: 10.1016/j.radonc.2008.06.010.

PMID:
18692265
13.

Image-guided high dose rate endorectal brachytherapy.

Devic S, Vuong T, Moftah B, Evans M, Podgorsak EB, Poon E, Verhaegen F.

Med Phys. 2007 Nov;34(11):4451-8.

PMID:
18072509
14.

PET-guided three-dimensional treatment planning of intracavitary gynecologic implants.

Mutic S, Grigsby PW, Low DA, Dempsey JF, Harms WB, Laforest R, Bosch WR, Miller TR.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1104-10.

PMID:
11958908
15.
16.

Direct reconstruction of the Vienna applicator on MR images.

Berger D, Dimopoulos J, Pötter R, Kirisits C.

Radiother Oncol. 2009 Nov;93(2):347-51. doi: 10.1016/j.radonc.2009.07.002.

PMID:
19625096
17.

Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy.

Hellebust TP, Kirisits C, Berger D, Pérez-Calatayud J, De Brabandere M, De Leeuw A, Dumas I, Hudej R, Lowe G, Wills R, Tanderup K; Gynaecological (GYN) GEC-ESTRO Working Group..

Radiother Oncol. 2010 Aug;96(2):153-60. doi: 10.1016/j.radonc.2010.06.004.

PMID:
20663578
18.

Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.

Nomden CN, de Leeuw AA, Van Limbergen E, de Brabandere M, Nulens A, Nout RA, Laman M, Ketelaars M, Lutgens L, Reniers B, Jürgenliemk-Schulz IM.

Radiother Oncol. 2013 Apr;107(1):82-7. doi: 10.1016/j.radonc.2012.10.002.

PMID:
23127774
19.

Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?

Davidson MT, Yuen J, D'Souza DP, Batchelar DL.

Brachytherapy. 2008 Jan-Mar;7(1):37-42. doi: 10.1016/j.brachy.2007.12.003.

PMID:
18299111
20.

Clinical implementation of MR-guided vaginal cylinder brachytherapy.

Owrangi AM, Jolly S, Balter JM, Cao Y, Maturen KE, Young L, Zhu T, Prisciandaro JI.

J Appl Clin Med Phys. 2015 Nov 8;16(6):5460.

PMID:
26699556

Supplemental Content

Support Center